PROFFERED PAPERS
Monday, March 19   —  1:00 PM   —  CC Ballroom C


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




Section B - Breast Pathology
Chaired by: Donald Weaver and I. Tolgay Ocal



TimeTitle and AuthorsItinerary
Planner
1:00 Biopsy Outcomes in Screen Detected Microcalcifications (146)
G Farshid, T Sullivan, P Downey, G Gill, S Pieterse - BreastScreen SA, Wayville, SA, Australia; SA Pathology, Adelaide, SA, Australia; University of Adelaide, Adelaide, SA, Australia
Add
1:15 Predictors of Local Recurrence (LR) in Patients with Ductal Carcinoma In Situ (DCIS) Treated by Breast Conserving Therapy (BCT): Value of the Memorial Sloan-Kettering (MSK) Nomogram (118)
LC Collins, N Achacoso, Z Sharafali, R Haque, L Nekhlyudov, SW Fletcher, CP Quesenberry, LA Habel, SJ Schnitt - Beth Israel Deaconess Medical Center, Boston; Harvard Medical School, Boston; Kaiser Permanente, Northern CA, Oakland; Kaiser Permanente, Southern CA, Pasadena; Harvard Vanguard Medical Associates, Boston
Add
1:30 c-MET Overexpression Is Associated with Breast Cancer Distant Metastasis and Loco-Regional Recurrence (95)
JP Bergeron, HT Richard, JA Almenara, MO Idowu - Virginia Commonwealth University, Richmond, VA
Add
1:45 Contralateral Breast Cancer Risk Following a Diagnosis of Ductal Carcinom In Situ (101)
FI Boulos, JF Simpson, PA Schuyler, WD Dupont, DL Page, ME Sanders - American University of Beruit, Beruit, Riad El Solh, Lebanon; Vanderbilt University, Nashville, TN
Add
2:00 Efficacy of Axillary Ultrasound Pre-Screening in Relation to Pathologic Parameters of Breast Carcinoma (295)
RJ Wolsky, CB Bills, H Sattar - University of Chicago, Chicago, IL
Add
2:15 Internal Impact of ACOSOG Z0011 at a Tertiary Academic Center (169)
D Jaggessarsingh, B Harmon, B O´Hea, P Farrelly, R Christine, T Carmen, M Singh - Stony Brook University Medical Center, Stony Brook, NY
Add
2:30 Multicentric Comparative Study between One-Step Nucleic Acid Amplification (OSNA) Whole Node Assay and Standard Histology for Breast Sentinel Lymph Node: Molecular Assay Can Avoid Secondary Surgeries and Predict No Other Node Involvement (258)
I Sansano, M Espinosa, C Iglesias, M Aizpurua, M Sancho, C Garcia, I Rubio, S Ramon y Cajal, V Peg - H. U. Vall d´Hebron, Barcelona, Spain; H. de Salamanca, Salamanca, Spain
Add
2:45 Lumpectomies for DCIS without Sentinel Node Biopsy – Patient Selection and 5 Year Follow-Up (230)
RK Patel, ML Cibull, PC McGrath, WR Heather, EA Pirruccello, VV Krol, YM Brill, LM Samayoa - Univeristy of Kentucky, Lexington, KY
Add
3:00 RECESS, EXHIBITS, POSTER SESSION II  
4:30 NATHAN KAUFMAN TIMELY TOPICS LECTURE
Bogdan Czerniak, MD, PhD
The Cancer Genome: A Step Towards Personalized Therapy
CC Ballroom A-D
Add